Skip to main content

Research Repository

Advanced Search

Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action Thumbnail


Abstract

Aluminium salts are by far the most commonly used adjuvants in vaccines. There are only two aluminium salts which are used in clinically-approved vaccines, Alhydrogel® and AdjuPhos®, while the novel aluminium adjuvant used in Gardasil® is a sulphated version of the latter. We have investigated the physicochemical properties of these two aluminium adjuvants and specifically in milieus approximating to both vaccine vehicles and the composition of injection sites. Additionally we have used a monocytic cell line to establish the relationship between their physicochemical properties and their internalisation and cytotoxicity. We emphasise that aluminium adjuvants used in clinically approved vaccines are chemically and biologically dissimilar with concomitantly potentially distinct roles in vaccine-related adverse events.

Acceptance Date Oct 26, 2018
Publication Date Nov 7, 2018
Publicly Available Date Mar 29, 2024
Journal Allergy Asthma and Clinical Immunology
Print ISSN 1710-1484
Publisher Springer Verlag
DOI https://doi.org/10.1186/s13223-018-0305-2
Keywords immunology
Publisher URL http://dx.doi.org/10.1186/s13223-018-0305-2

Files




Downloadable Citations